MedTrace Logo

Prospective Clinical Trial of Three Apical Sealing Materials

NCT04198298 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2019-12-13

No results posted yet for this study

Summary

This prospective comparative randomized clinical trial compares healing and bony regeneration in patients who received 1 of 3 different retrograde filling materials following microsurgical apicoectomies for the treatment of periapical lesions of endodontic origin.

Conditions

  • Periapical Abscess

Interventions

DRUG

EndoSequence

The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.

DRUG

ProRoot MTA

The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.

DRUG

Biodentine

The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.

Sponsors & Collaborators

  • University of the Pacific

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-02
Primary Completion
2017-05-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04198298 on ClinicalTrials.gov